Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Aug 11, 2020 at 9:41 AM EDT

5 Speculative Biotechs With 50% to 300% Implied Upside

24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300%…

Chris Lange | Aug 10, 2020 at 10:09 AM EDT

Good News for C Diff Sufferers and Seres Therapeutics Investors

Seres Therapeutics shares more than tripled early on Monday after the firm announced positive late-stage results for its C. difficile…

Chris Lange | Aug 7, 2020 at 11:11 AM EDT

Investors Cheer AnPac Bio’s Coronavirus Developments

AnPac Bio-Medical Science shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.

Jon C. Ogg | Aug 7, 2020 at 10:51 AM EDT

Biogen Has Potentially Great News in the Fight Against Alzheimer’s

The world may be focused on COVID-19 this year, but the battle against Alzheimer’s disease continues with no effective treatments.…

Chris Lange | Aug 6, 2020 at 11:14 AM EDT

Denali Therapeutics Takes Next Big Step in Treating Parkinson’s

Denali Therapeutics announced early Thursday that it would be progressing its Parkinson’s treatment into late-stage studies in collaboration with Biogen.

Chris Lange | Aug 5, 2020 at 11:21 AM EDT

Novavax Bulls Keep Charging as More COVID-19 Results Come Out

Novavax shares hit another all-time high on Wednesday after the company announced positive results from its early stage COVID-19 vaccine…

Chris Lange | Aug 5, 2020 at 10:07 AM EDT

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19

24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense,…

Paul Ausick | Aug 5, 2020 at 8:11 AM EDT

How the COVID-19 Pandemic Drove Q2 Earnings at CVS

Pharmacy and health insurer CVS handily beat expected earnings and revenue estimates for the second quarter.

Chris Lange | Aug 4, 2020 at 11:22 AM EDT

Is Regneron’s COVID-19 Animal Study Giving More Creedence to Antibody Treatments?

Regeneron Pharmaceuticals, one of the front-runners for the development of a COVID-19 treatment, released an update on its antibody drug…

Chris Lange | Aug 4, 2020 at 10:28 AM EDT

What You Need to Know About Alterity Therapeutics’ Tuesday Move

Alterity Therapeutics stock more than doubled on Tuesday after the company announced new data for its lead drug candidate for…

Chris Lange | Aug 4, 2020 at 10:04 AM EDT

Is European Update Overshadowing Amarin’s Lackluster Earnings?

Amarin reported its latest quarterly results on Tuesday morning and gave an update on the most recent developments with its…

Jon C. Ogg | Aug 3, 2020 at 1:39 PM EDT

The Nasty Surprise From Eastman Kodak

All those investors who were buying into the hype that Kodak will be a major player in making materials for…

Chris Lange | Aug 3, 2020 at 12:03 PM EDT

CymaBay Pulls Off Another Win With PBC Liver Disease Study

CymaBay Therapeutics posted a huge gain to start off the week after the company reported results from a late-stage clinical…

Chris Lange | Aug 3, 2020 at 9:50 AM EDT

How GW Pharma Is Expanding Its Cannabidiol Seizure Treatment

GW Pharmaceuticals shares popped early on Monday morning after the company announced that it received a key approval from the…

Douglas A. McIntyre | Aug 1, 2020 at 8:44 AM EDT

US COVID-19 Deaths May Hit 200,000 by Labor Day

Over the past few days, more than 1,000 people have died from COVID-19 per day in the United States. At…

1 … 45 46 47 48 49 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

5 Speculative Biotechs With 50% to 300% Implied Upside

Good News for C Diff Sufferers and Seres Therapeutics Investors

Investors Cheer AnPac Bio’s Coronavirus Developments

Biogen Has Potentially Great News in the Fight Against Alzheimer’s

Denali Therapeutics Takes Next Big Step in Treating Parkinson’s

Novavax Bulls Keep Charging as More COVID-19 Results Come Out

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19

How the COVID-19 Pandemic Drove Q2 Earnings at CVS

Is Regneron’s COVID-19 Animal Study Giving More Creedence to Antibody Treatments?

What You Need to Know About Alterity Therapeutics’ Tuesday Move

Is European Update Overshadowing Amarin’s Lackluster Earnings?

The Nasty Surprise From Eastman Kodak

CymaBay Pulls Off Another Win With PBC Liver Disease Study

How GW Pharma Is Expanding Its Cannabidiol Seizure Treatment

US COVID-19 Deaths May Hit 200,000 by Labor Day

What JEPQ Actually Paid the Last Time the Nasdaq Fell 10%: a Stress Test for Its 10% Yield

VOO Is About to Become the First $1 Trillion ETF, and SPY Holders Are Paying 3x More for the Same Index

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

What JEPQ Actually Paid the Last Time the Nasdaq Fell 10%: a Stress Test for Its 10% Yield

VOO Is About to Become the First $1 Trillion ETF, and SPY Holders Are Paying 3x More for the Same Index

Health and Healthcare Articles

All Health and Healthcare Articles

5 Speculative Biotechs With 50% to 300% Implied Upside

Good News for C Diff Sufferers and Seres Therapeutics Investors

Investors Cheer AnPac Bio’s Coronavirus Developments

Biogen Has Potentially Great News in the Fight Against Alzheimer’s

Denali Therapeutics Takes Next Big Step in Treating Parkinson’s

Novavax Bulls Keep Charging as More COVID-19 Results Come Out

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19

How the COVID-19 Pandemic Drove Q2 Earnings at CVS

Is Regneron’s COVID-19 Animal Study Giving More Creedence to Antibody Treatments?

What You Need to Know About Alterity Therapeutics’ Tuesday Move

Is European Update Overshadowing Amarin’s Lackluster Earnings?

The Nasty Surprise From Eastman Kodak

CymaBay Pulls Off Another Win With PBC Liver Disease Study

How GW Pharma Is Expanding Its Cannabidiol Seizure Treatment

US COVID-19 Deaths May Hit 200,000 by Labor Day

What JEPQ Actually Paid the Last Time the Nasdaq Fell 10%: a Stress Test for Its 10% Yield

VOO Is About to Become the First $1 Trillion ETF, and SPY Holders Are Paying 3x More for the Same Index

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

Featured Reads

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later